These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16779736

  • 1. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.
    Scollard DM, Joyce MP, Gillis TP.
    Clin Infect Dis; 2006 Jul 15; 43(2):e19-22. PubMed ID: 16779736
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
    Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T.
    Arthritis Rheum; 2006 Dec 15; 54(12):3782-9. PubMed ID: 17133559
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V, Pontikaki I, Gattinara M, Fantini F.
    Ann Rheum Dis; 2008 Aug 15; 67(8):1145-52. PubMed ID: 17981916
    [Abstract] [Full Text] [Related]

  • 6. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab.
    Esser AC, Abril A, Fayne S, Doyle JA.
    J Am Acad Dermatol; 2004 May 15; 50(5 Suppl):S75-7. PubMed ID: 15097933
    [Abstract] [Full Text] [Related]

  • 7. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY, Browning JC, Larsen F, Hsu S.
    Dermatol Online J; 2008 Sep 15; 14(9):12. PubMed ID: 19061594
    [Abstract] [Full Text] [Related]

  • 8. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR, Gilliland WR, Miller RS, Decker CF.
    Scand J Infect Dis; 2009 Sep 15; 41(4):252-5. PubMed ID: 19266397
    [Abstract] [Full Text] [Related]

  • 9. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
    Geraghty EM, Ristow B, Gordon SM, Aronowitz P.
    Clin Infect Dis; 2007 May 15; 44(10):e82-4. PubMed ID: 17443458
    [Abstract] [Full Text] [Related]

  • 10. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG, Colmenero JD, Irigoyen MV.
    J Infect; 2005 May 15; 50(4):370-1. PubMed ID: 15845443
    [No Abstract] [Full Text] [Related]

  • 11. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
    Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euller-Ziegler L.
    J Rheumatol; 2007 Feb 15; 34(2):434-7. PubMed ID: 17295430
    [Abstract] [Full Text] [Related]

  • 12. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov 15; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
    Moustou AE, Stratigos AJ, Vergou T, Gregoriou S, Georgala S, Danopoulou I.
    J Eur Acad Dermatol Venereol; 2009 Aug 15; 23(8):968-9. PubMed ID: 19207660
    [No Abstract] [Full Text] [Related]

  • 15. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
    Richette P, Viguier M, Bachelez H, Bardin T.
    J Rheumatol; 2007 Feb 15; 34(2):438-9. PubMed ID: 17304662
    [No Abstract] [Full Text] [Related]

  • 16. Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment.
    Levälampi T, Korpela M, Vuolteenaho K, Moilanen E.
    Scand J Rheumatol; 2008 Feb 15; 37(1):6-12. PubMed ID: 18189188
    [Abstract] [Full Text] [Related]

  • 17. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A, Kannangara S, Barnsley L.
    Intern Med J; 2005 Oct 15; 35(10):638-40. PubMed ID: 16207269
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.